Literature DB >> 9547000

Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43.

W E Müller1, G P Eckert, K Scheuer, N J Cairns, A Maras, W F Gattaz.   

Abstract

beta-amyloid peptide (A beta) and several A beta-fragments decrease the fluidity of human cortex membranes in a concentration dependent fashion. The effect of A beta on membrane fluidity increases with peptide length, is most pronounced for A beta 1-43 and can be seen at concentrations as low as 100 nmol/l. While the fragment A beta 25-35 is active, scrambled peptide (A beta 35-25) when investigated under similar conditions shows no effects on membrane fluidity. The effect of A beta peptides on fluidity of the phospholipid bilayer is more pronounced in the hydrocarbon core (labeled with the fluorescence probe 1,6-diphenylhexa-1,3,5-triene) than in the region of the hydrophilic heads (labeled with the fluorescence probe 1-[4'-(trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene). It is suggested that the effect of A beta on neuronal membranes is probably a major initial mechanism in a cascade of events finally leading to neurotoxicity and cell death in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9547000     DOI: 10.3109/13506129809007284

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  10 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides.

Authors:  S P Koo; A S Bayer; M R Yeaman
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats.

Authors:  M S Clarke; M A Prendergast; A V Terry
Journal:  Learn Mem       Date:  1999 Nov-Dec       Impact factor: 2.460

Review 4.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

Authors:  Vijayaraghavan Rangachari; Dexter N Dean; Pratip Rana; Ashwin Vaidya; Preetam Ghosh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-09       Impact factor: 3.747

Review 5.  Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis.

Authors:  Qiujian Yu; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2017-11-24       Impact factor: 5.203

6.  Unsaturated fatty acids drive disintegrin and metalloproteinase (ADAM)-dependent cell adhesion, proliferation, and migration by modulating membrane fluidity.

Authors:  Karina Reiss; Isabell Cornelsen; Matthias Husmann; Gerald Gimpl; Sucharit Bhakdi
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

7.  Aggregated beta amyloid peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic phospholipase C in brain cortex.

Authors:  A Zambrzycka; R P Strosznajder; J B Strosznajder
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

8.  Amyloid beta peptide impaired carbachol but not glutamate-mediated phosphoinositide pathways in cultured rat cortical neurons.

Authors:  H M Huang; H C Ou; S J Hsieh
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

9.  Interaction of amyloid beta-protein with anionic phospholipids: possible involvement of Lys28 and C-terminus aliphatic amino acids.

Authors:  A Chauhan; I Ray; V P Chauhan
Journal:  Neurochem Res       Date:  2000-03       Impact factor: 3.996

10.  Amyloid-beta peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A2.

Authors:  Jacob B Hicks; Yinzhi Lai; Wenwen Sheng; Xiaoguang Yang; Donghui Zhu; Grace Y Sun; James C-M Lee
Journal:  Biochim Biophys Acta       Date:  2008-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.